Dr. Ella Veitsman, MD
Claim this profileRambam Health Care Center
Studies Choledocholithiasis, Cholangitis
Studies Non-alcoholic Fatty Liver Disease
10 reported clinical trials
13 drugs studied
Clinical Trials Ella Veitsman, MD is currently running
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Recruiting1 award Phase 31 criteria
Volixibat
for Itching in Primary Sclerosing Cholangitis
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Recruiting0 awards Phase 26 criteria
More about Ella Veitsman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ella Veitsman, MD has experience with
- Placebo
- Linerixibat
- Peginterferon Lambda-1a
- Belapectin
- Volixibat
- EP547
Breakdown of trials Ella Veitsman, MD has run
Choledocholithiasis, Cholangitis
Non-alcoholic Fatty Liver Disease
Primary Sclerosing Cholangitis
Primary Biliary Cirrhosis
Hepatitis D
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Ella Veitsman, MD specialize in?
Is Ella Veitsman, MD currently recruiting for clinical trials?
Are there any treatments that Ella Veitsman, MD has studied deeply?
What is the best way to schedule an appointment with Ella Veitsman, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.